Found: 14
Select item for more details and to access through your institution.
Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virusassociated gastric cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1003859
- By:
- Publication type:
- Article
Postoperative subphenotypes modified the hepatoma arterial-embolization prognostic score: A novel smHAP-II nomogram.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 10, p. 2940, doi. 10.7150/jca.91175
- By:
- Publication type:
- Article
Development and Validation of Deep Learning Model for Intermediate-Stage Hepatocellular Carcinoma Survival with Transarterial Chemoembolization (MC-hccAI 002): a Retrospective, Multicenter, Cohort Study.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 7, p. 2066, doi. 10.7150/jca.91501
- By:
- Publication type:
- Article
The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 8, p. 1272, doi. 10.7150/jca.79377
- By:
- Publication type:
- Article
Latent Class Analysis of Subphenotypes in Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization.
- Published in:
- Journal of Cancer, 2022, v. 13, n. 12, p. 3318, doi. 10.7150/jca.76021
- By:
- Publication type:
- Article
Prognostic nomogram to predict the overall survival of patients with early-onset colorectal cancer: a population-based analysis.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 9, p. 1981, doi. 10.1007/s00384-021-03992-w
- By:
- Publication type:
- Article
Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 4, p. 620, doi. 10.1038/s41416-023-02334-7
- By:
- Publication type:
- Article
Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Frontiers in Pharmacology, 2020, v. 10, p. 1, doi. 10.3389/fphar.2020.00005
- By:
- Publication type:
- Article
Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8663, doi. 10.2147/CMAR.S328451
- By:
- Publication type:
- Article
Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population‐based study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5275, doi. 10.1002/cam4.5334
- By:
- Publication type:
- Article
DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 3, p. 252, doi. 10.20892/j.issn.2095-3941.2023.0303
- By:
- Publication type:
- Article
Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.618937
- By:
- Publication type:
- Article
Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221964
- By:
- Publication type:
- Article
Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1327691
- By:
- Publication type:
- Article